"Hemofiltration" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Extracorporeal ULTRAFILTRATION technique without HEMODIALYSIS for treatment of fluid overload and electrolyte disturbances affecting renal, cardiac, or pulmonary function.
| Descriptor ID |
D006440
|
| MeSH Number(s) |
E04.292.471
|
| Concept/Terms |
Venovenous Hemofiltration- Venovenous Hemofiltration
- Hemofiltration, Venovenous
- Hemofiltrations, Venovenous
- Venovenous Hemofiltrations
Arteriovenous Hemofiltration- Arteriovenous Hemofiltration
- Arteriovenous Hemofiltrations
- Hemofiltration, Arteriovenous
- Hemofiltrations, Arteriovenous
Hemofiltration, Continuous Arteriovenous- Hemofiltration, Continuous Arteriovenous
- Arteriovenous Hemofiltration, Continuous
- Arteriovenous Hemofiltrations, Continuous
- Continuous Arteriovenous Hemofiltration
- Continuous Arteriovenous Hemofiltrations
- Hemofiltrations, Continuous Arteriovenous
- CAVH
|
Below are MeSH descriptors whose meaning is more general than "Hemofiltration".
Below are MeSH descriptors whose meaning is more specific than "Hemofiltration".
This graph shows the total number of publications written about "Hemofiltration" by people in this website by year, and whether "Hemofiltration" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2009 | 2 | 0 | 2 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 9 | 4 | 13 |
| 2018 | 11 | 6 | 17 |
| 2019 | 5 | 1 | 6 |
| 2020 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hemofiltration" by people in Profiles.
-
Pharmacokinetics of Remdesivir and GS-441524 during PIRRT and Seraph 100 Therapy. Clin J Am Soc Nephrol. 2021 08; 16(8):1256-1257.
-
Hemofiltration with the Seraph® 100 Microbind® Affinity filter decreases SARS-CoV-2 nucleocapsid protein in critically ill COVID-19 patients. Crit Care. 2021 06 01; 25(1):190.
-
Application of extracorporeal carbon dioxide removal combined with continuous blood purification therapy in ARDS with hypercapnia in patients with critical COVID-19. Clin Hemorheol Microcirc. 2021; 78(2):199-207.
-
Early Cytokine Removal in Critical COVID-19 Patients with Extracorporeal Therapies (HA-380 plus High Volume Hemofiltration) May Prevent Progression of Acute Respiratory Distress Syndrome: Case Report. Blood Purif. 2021; 50(4-5):575-577.
-
Immunomodulation using CONVEHY® for COVID-19: from the storm to the cytokine anticyclone. Rev Esp Anestesiol Reanim (Engl Ed). 2021 Feb; 68(2):107-112.
-
Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19). BMC Nephrol. 2020 08 20; 21(1):356.
-
COVID-19 infection in children and adolescents. Br J Hosp Med (Lond). 2020 Aug 02; 81(8):1-10.
-
Renal replacement therapy in critically ill patients with COVID-19: A retrospective study investigating mortality, renal recovery and filter lifetime. J Crit Care. 2020 12; 60:103-105.
-
Clearance of chloroquine and hydroxychloroquine by the Seraph® 100 Microbinda Affinity Blood Filter -a device approved for the treatment of COVID-19 patients. Ther Apher Dial. 2021 Apr; 25(2):237-241.
-
The Combined Use of Tocilizumab and Hemoadsorption in a Patient with SARS-COV-2-19-Associated Pneumonia: A Case Report. Nephron. 2020; 144(9):459-462.